Orally delivered all-trans-retinoic acid- and transforming growth factor-β-loaded microparticles ameliorate type 1 diabetes in mice
Ivan Koprivica(University of Belgrade), Ivana Stojanović(University of Belgrade), Eugenio Cavalli(Centro Neurolesi Bonino Pulejo), Nada Pejnović(University of Kragujevac), Stanislava Stošić‐Grujičić(Institute for Biological Research “Siniša Stanković”), Sanja Despotović(University of Belgrade), Ferdinando Nicoletti(University of Catania), Dominick L. Auci(Athenex (United States)), Dragica Gajić(University of Belgrade), Tamara Saksida(University of Belgrade)
Cited by 23
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495